Investec Bank Plc has filed a Form 8.5 disclosure under Rule 8.5 of the Takeover Code in relation to Advanced Medical Solutions Group Plc.
The filing identifies Investec as acting in its capacity as an exempt principal trader with recognised intermediary status dealing in a client-serving capacity.
Investec serves as Advisor and Joint Broker to Advanced Medical Solutions Group Plc, establishing its connection to the relevant party in the offer.
The dealing was undertaken on 22nd September 2026, with the disclosure itself published on 23rd September 2026.
According to the filing, Investec Bank Plc purchased a total of 13,530 ordinary shares in Advanced Medical Solutions Group Plc during the disclosed dealing period.
Both the highest and lowest price per unit paid for those shares was recorded at 282.25 pence, indicating all transactions were executed at a single uniform price.
No cash-settled derivative transactions were reported as part of this disclosure, with those sections of the form recorded as not applicable.
Similarly, no stock-settled derivative transactions, including options of any kind, were reported within the filing documentation.
Investec confirmed that no indemnity arrangements, option arrangements, or other agreements relating to relevant securities were in place that could constitute an inducement to deal or refrain from dealing.
The bank also confirmed the absence of any agreements or understandings relating to voting rights or future acquisition and disposal of securities to which any derivative is referenced.
Public disclosures of this type under Rule 8 of the Takeover Code are required to be submitted to a Regulatory Information Service for transparency purposes.
The contact named within the filing is Priyali Bhattacharjee, reachable by telephone for any related enquiries regarding the disclosed dealings.
